Natural Beauty Bio-Technology Limited (HKG:0157)
Hong Kong · Delayed Price · Currency is HKD 0.4600
-0.0050 (-1.08%)
Jul 31, 2026, 3:55 PM HKT
HKG:0157 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 10.58 | -103.62 | -15.11 | -30.47 | 35.26 |
Depreciation & Amortization | 38.79 | 31.67 | 26.65 | 34.3 | 34.95 |
Loss (Gain) From Sale of Assets | 1.18 | -0.19 | -0 | 0.6 | 0.39 |
Asset Writedown & Restructuring Costs | 8.04 | 48.94 | 5.76 | 5.93 | -0.53 |
Loss (Gain) on Equity Investments | 0.9 | - | - | - | - |
Provision & Write-off of Bad Debts | 1.22 | -0.12 | -4.08 | 4.72 | -3.98 |
Other Operating Activities | 6 | 6.45 | 4.1 | -3.4 | 14.35 |
Change in Accounts Receivable | -76 | 9.21 | 1.02 | 19.72 | 6.74 |
Change in Inventory | -17.01 | -8.22 | 16.51 | -1.01 | -27.03 |
Change in Accounts Payable | 13.51 | 4.74 | -16.1 | -23.26 | -16.56 |
Change in Unearned Revenue | -3.66 | -1.3 | 3.23 | 4.42 | 1.33 |
Change in Other Net Operating Assets | 0.96 | -1.31 | -0.26 | 0.01 | -0.31 |
Operating Cash Flow | -15.51 | -13.75 | 21.72 | 11.56 | 44.62 |
Operating Cash Flow Growth | - | - | 87.96% | -74.09% | 48.03% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -68.25 | -41.21 | -69.12 | -44.31 | -38.11 |
Sale of Property, Plant & Equipment | 2.64 | 0.19 | 0 | 0.33 | 3.31 |
Divestitures | - | - | - | - | 4.85 |
Investment in Securities | -3.33 | - | - | - | - |
Other Investing Activities | 0.56 | 0.85 | 1.51 | 5.21 | 0.8 |
Investing Cash Flow | -68.39 | -40.17 | -67.61 | -38.77 | -29.16 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 164.79 | 195.29 | 109.1 | 53.22 | 54.24 |
Long-Term Debt Repaid | -80.18 | -172.49 | -59.45 | -29.12 | -33.92 |
Net Debt Issued (Repaid) | 84.61 | 22.8 | 49.65 | 24.1 | 20.31 |
Common Dividends Paid | - | - | - | -6.01 | -6.01 |
Other Financing Activities | -9.47 | -7.46 | -7.02 | -4.89 | -3.89 |
Financing Cash Flow | 75.14 | 15.34 | 42.63 | 13.21 | 10.42 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 4.02 | -11.13 | 1.41 | -9.87 | 4.06 |
Net Cash Flow | -4.74 | -49.71 | -1.85 | -23.87 | 29.94 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -83.76 | -54.96 | -47.39 | -32.75 | 6.5 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -15.54% | -15.54% | -14.10% | -9.75% | 1.33% |
Free Cash Flow Per Share | -0.04 | -0.03 | -0.02 | -0.02 | 0.00 |
Levered Free Cash Flow | -67.72 | -38.78 | -46.81 | 22.49 | 4.44 |
Unlevered Free Cash Flow | -61.18 | -33.75 | -41.73 | 25.21 | 5.58 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 10.47 | 8.05 | 8.13 | 6.18 | 4.87 |
Cash Income Tax Paid | 5.78 | 4.77 | 8.4 | 24.28 | 9.57 |
Change in Working Capital | -82.21 | 3.12 | 4.4 | -0.12 | -35.83 |